Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|December 3, 2010
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infectionWillize E van der Starre, Cees van Nieuwkoop, Sunita Paltansing, et al.
The Lancet. Infectious Diseases|March 7, 2017
Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trialMarijn de Bruin, Edwin J M Oberjé, Wolfgang Viechtbauer, et al.
Open Forum Infectious Diseases|February 22, 2021
Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort StudyCas J Isfordink, Thijs J W van de Laar, Sjoerd P H Rebers, et al.
Open Forum Infectious Diseases|August 11, 2021
Erratum to: Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort StudyCas J Isfordink, Thijs J W van de Laar, Sjoerd P H Rebers, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 28, 2024
Patients' Perspectives and Feasibility of Home Monitoring in Acute Care: The AcuteCare@Home Flash Mob StudyJari Weijers, Manon L M Prins, Davy G H A van Dam, et al.
BMC Infectious Diseases|August 21, 2009
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)Cees van Nieuwkoop, Jan W van't Wout, Willem J J Assendelft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic EvaluationBen F M Wijnen, Edwin J M Oberjé, Silvia M A A Evers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter TrialThijs Ten Doesschate, Sander Kuiper, Cees van Nieuwkoop, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 3, 2023
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trialEva L Koekenbier, Konstantin Fohse, Josephine S van de Maat, et al.
BMJ Open|August 17, 2023
Evaluation of an integrated care pathway for out-of-hospital treatment of older adults with an acute moderate-to-severe lower respiratory tract infection or pneumonia: protocol of a mixed methods studyRick Roos, Rianne M C Pepping, Maarten O van Aken, et al.
Pageof 9